Yoo Yeok-jin

Japanese semiconductor equipment stocks are in a powerful capex cycle mirroring 1998-99; companies like Tokyo Electron and others will benefit as Korean and global chipmakers ramp capacity through 2028. The recent surge of Kioxia to Japan's top market cap signals the sector's momentum, and a dedicated Japanese equipment ETF provides a concentrated way to play it.

With oil prices likely to break below $80 within 2-3 months and the peace deal easing inflation fears, biotech and healthcare will see a return of buying interest. The pattern resembles mid-2022 when falling oil triggered an IBB (US biotech ETF) rally, and Korean biotech stocks will similarly benefit from lower rates and flows rotating out of crowded semiconductor positions.